This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Whitlow, J Articles by Sistino, J. Search for Related Content PubMed PubMed Citation Articles by Whitlow, J Articles by Sistino, J. Social Bookmarking                         What's this?

Barriers to the acceptance and use of autologous platelet gel

Cardiovascular Perfusion Program, Medical University of South Carolina, College of Health Professions, Charleston, SC, USA

AG Shackelford

Cardiovascular Perfusion Program, Medical University of South Carolina, College of Health Professions, Charleston, SC, USA

AN Sievert

Cardiovascular Perfusion Program, Medical University of South Carolina, College of Health Professions, Charleston, SC, USA

JJ Sistino

Cardiovascular Perfusion Program, Medical University of South Carolina, College of Health Professions, Charleston, SC, USA sistinoj{at}musc.edu

The process of producing and applying platelet concentrate (gel) to wounds has been shown by several researchers to accelerate healing and promote tissue regeneration in a broad spectrum of healthcare practices. Despite the evidence, widespread adoption of this technology has not occurred. The purpose of this research is to identify those factors acting as barriers to the adoption of platelet gel use. Subscribers to Perflist and Perfmail, online perfusion community listservs, were invited to participate in an online survey designed to identify factors influencing platelet gel adoption. Respondents provided their opinions on cost, clinical application, effectiveness, and perceived barriers to adoption and use of platelet gel. Statistical analysis of the non-user responses identifies lack of reimbursement and physician acceptance as significant barriers to the adoption of platelet gel. Questionable efficacy, cost, additional training, and the lack of personnel do not appear to be significant barriers to the use of platelet gel. There does not appear to be a significant difference among the user and non-user employment distributions. This study suggests that education of physicians via literature reviews or in-service plays a significant role in gaining adoption of platelet gel.

Key Words: autologous platelet gel • hemostasis • platelet rich plasma

Perfusion, Vol. 23, No. 5, 283-289 (2008)
DOI: 10.1177/0267659109104426


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?